Works matching AU Mukherjee, Sudipto


Results: 70
    1
    2
    3
    4

    Risk for Developing Myelodysplastic Syndromes in Prostate Cancer Patients DefinitivelyTreated With Radiation.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 3, p. 1, doi. 10.1093/jnci/djt462
    By:
    • Mukherjee, Sudipto;
    • Reddy, Chandana A.;
    • Ciezki, Jay R.;
    • Abdel-Wahab, May;
    • Tiu, Ramon V.;
    • Copelan, Edward;
    • Advani, Anjali A.;
    • Saunthararajah, Yogen;
    • Paulic, Katarina;
    • Hobson, Sean;
    • Maciejewski, Jaroslaw R.;
    • Bolwell, Brian J.;
    • Kalaycio, Matt;
    • Dreicer, Robert;
    • Klein, Eric A.;
    • Sekeres, Mikkael A.
    Publication type:
    Article
    5

    Cancer burden in women with HIV on Medicaid: A nationwide analysis.

    Published in:
    Women's Health (17455057), 2023, p. 1, doi. 10.1177/17455057231170061
    By:
    • Zhou, Guangjin;
    • Koroukian, Siran M;
    • Navale, Suparna M;
    • Schiltz, Nicholas K;
    • Kim, Uriel;
    • Rose, Johnie;
    • Cooper, Gregory S;
    • Moore, Scott E;
    • Mintz, Laura J;
    • Avery, Ann K;
    • Mukherjee, Sudipto;
    • Markt, Sarah C
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    PB2017: CLINICAL OUTCOMES BY SF3B1 MUTATION STATUS IN PATIENTS WITH LOWER‐RISK MYELODYSPLASTIC SYNDROMES RETREATED WITH ERYTHROPOIESIS‐STIMULATING AGENTS.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000974880.20066.a9
    By:
    • Garcia‐Manero, Guillermo;
    • Matsuno, Rayna K.;
    • Mcbride, Ali;
    • Makinde, Adeola Y;
    • Brown, Thomas D.;
    • Idryo, Danny;
    • Broome, Ronda;
    • Herriman, Autumn;
    • Wilkinson, Kristiana;
    • Walters, Sheetal;
    • Schrag, Andrew;
    • Mohammed, Hina;
    • Izano, Monika A.;
    • Mukherjee, Sudipto
    Publication type:
    Article
    16
    17
    18
    19
    20

    Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review.

    Published in:
    PLoS ONE, 2021, v. 16, n. 3, p. 1, doi. 10.1371/journal.pone.0249087
    By:
    • Chang, Yaping;
    • Guyatt, Gordon H.;
    • Teich, Trevor;
    • Dawdy, Jamie L.;
    • Shahid, Shaneela;
    • Altman, Jessica K.;
    • Stone, Richard M.;
    • Sekeres, Mikkael A.;
    • Mukherjee, Sudipto;
    • LeBlanc, Thomas W.;
    • Abel, Gregory A.;
    • Hourigan, Christopher S.;
    • Litzow, Mark R.;
    • Michaelis, Laura C.;
    • Alibhai, Shabbir M. H.;
    • Desai, Pinkal;
    • Buckstein, Rena;
    • MacEachern, Janet;
    • Brignardello-Petersen, Romina
    Publication type:
    Article
    21
    22
    23
    24

    Prognostic impact of incomplete hematologic count recovery and minimal residual disease on outcome in adult acute lymphoblastic leukemia at the time of second complete response.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 2, p. 363, doi. 10.1080/10428194.2017.1344842
    By:
    • Saygin, Caner;
    • Papadantonakis, Nikolaos;
    • Cassaday, Ryan D.;
    • Liedtke, Michaela;
    • Fischer, Katrina;
    • Dunn, Tamara;
    • Patel, Bhumika J.;
    • Sobecks, Ronald;
    • Kalaycio, Matt;
    • Sekeres, Mikkael A.;
    • Mukherjee, Sudipto;
    • Gerds, Aaron T.;
    • Hamilton, Betty K.;
    • Carraway, Hetty E.;
    • Advani, Anjali S.
    Publication type:
    Article
    25
    26
    27
    28
    29

    Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 12, p. 1553, doi. 10.1002/ajh.25992
    By:
    • Fajgenbaum, David C.;
    • Wu, David;
    • Goodman, Aaron;
    • Wong, Raymond;
    • Chadburn, Amy;
    • Nasta, Sunita;
    • Srkalovic, Gordan;
    • Mukherjee, Sudipto;
    • Leitch, Heather;
    • Jayanthan, Raj;
    • Ferrero, Simone;
    • Sato, Yasuharu;
    • Schey, Steve;
    • Dispenzieri, Angela;
    • Oksenhendler, Eric;
    • Zinzani, Pier Luigi;
    • Lechowicz, Mary Jo;
    • Hoffmann, Christian;
    • Pemmaraju, Naveen;
    • Bagg, Adam
    Publication type:
    Article
    30
    31
    32
    33
    34

    DOCK 6: Impact of new features and current docking performance.

    Published in:
    Journal of Computational Chemistry, 2015, v. 36, n. 15, p. 1132, doi. 10.1002/jcc.23905
    By:
    • Allen, William J.;
    • Balius, Trent E.;
    • Mukherjee, Sudipto;
    • Brozell, Scott R.;
    • Moustakas, Demetri T.;
    • Lang, P. Therese;
    • Case, David A.;
    • Kuntz, Irwin D.;
    • Rizzo, Robert C.
    Publication type:
    Article
    35
    36
    37

    Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes.

    Published in:
    Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-13001-y
    By:
    • Yasunobu Nagata;
    • Hideki Makishima;
    • Kerr, Cassandra M.;
    • Przychodzen, Bartlomiej P.;
    • Aly, Mai;
    • Goyal, Abhinav;
    • Awada, Hassan;
    • Asad, Mohammad Fahad;
    • Kuzmanovic, Teodora;
    • Hiromichi Suzuki;
    • Tetsuichi Yoshizato;
    • Kenichi Yoshida;
    • Kenichi Chiba;
    • Hiroko Tanaka;
    • Yuichi Shiraishi;
    • Satoru Miyano;
    • Mukherjee, Sudipto;
    • LaFramboise, Thomas;
    • Nazha, Aziz;
    • Sekeres, Mikkael A.
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Clinical Outcomes and Healthcare Resource Utilization for Patients With Lower-Risk Myelodysplastic Syndromes Treated With Erythropoiesis-Stimulating Agents.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 9, p. e283, doi. 10.1016/j.clml.2024.05.007
    By:
    • Garcia-Manero, Guillermo;
    • Matsuno, Rayna K.;
    • McBride, Ali;
    • Mohammed, Hina;
    • Idryo, Danny;
    • Broome, Ronda;
    • Herriman, Autumn;
    • Johnson, Tiffany;
    • Wilkinson, Kristiana;
    • Schrag, Andrew;
    • Johanson, Colden;
    • Izano, Monika;
    • Makinde, Adeola;
    • Mukherjee, Sudipto
    Publication type:
    Article
    47
    48
    49

    TP53 Mutations in Myeloid Neoplasms and Clonal Hematopoiesis of Indeterminate Potential following Cytotoxic Therapy for Antecedent Malignancy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S264, doi. 10.1016/j.clml.2018.07.178
    By:
    • Kuzmanovic, Teodora;
    • Radivoyevitch, Tomas;
    • Sanikommu, Srinivasa;
    • Patel, Bhumika;
    • Nagata, Yasunobu;
    • Hirsch, Cassandra;
    • Przychodzen, Bartlomiej;
    • Awada, Hassan;
    • Mukherjee, Sudipto;
    • Advani, Anjali;
    • Nazha, Aziz;
    • Gerds, Aaron;
    • Carraway, Hetty;
    • Sekeres, Mikkael;
    • Maciejewski, Jaroslaw
    Publication type:
    Article
    50

    Mutational Landscape of Therapy-Related Myeloid Neoplasms.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S263, doi. 10.1016/j.clml.2018.07.177
    By:
    • Kuzmanovic, Teodora;
    • Radivoyevitch, Tomas;
    • Sanikommu, Srinivasa;
    • Patel, Bhumika;
    • Nagata, Yasunobu;
    • Hirsch, Cassandra;
    • Przychodzen, Bartlomiej;
    • Awada, Hassan;
    • Mukherjee, Sudipto;
    • Advani, Anjali;
    • Nazha, Aziz;
    • Gerds, Aaron;
    • Carraway, Hetty;
    • Sekeres, Mikkael;
    • Maciejewski, Jaroslaw
    Publication type:
    Article